Trials / Completed
CompletedNCT01807117
PET-MRI in Diagnosing Patients With Colon or Rectal Cancer
Evaluation of PET-MRI in Initial Staging of High Grade Rectal Cancer Patients and in the Follow up of Colorectal Cancer Patients.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Case Comprehensive Cancer Center · Academic / Other
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
This pilot clinical trial studies positron emission tomography (PET)-magnetic resonance imaging (MRI) and PET-computed tomography (CT) as diagnostic imaging in patients with colon and/or rectal cancer. New diagnostic imaging procedures, such as PET-MRI, may help find and diagnose rectal cancer or recurrence of colorectal cancer
Detailed description
PRIMARY OBJECTIVES: I. To test the diagnostic performance of PET- MRI in the staging of preoperative high-grade rectal cancer patients, defined by T3 stage or higher or N1 stage or higher or presence of metastasis, that are referred to PET-CT and MRI. II. To test the diagnostic performance of PET-MRI the follow up of colorectal cancer patients that are referred to PET-CT with or without a diagnostic MRI request by their physicians. SECONDARY OBJECTIVES: I. To test different attenuation correction MR sequences and novel diagnostic MR sequences. OUTLINE: Patients undergo fludeoxyglucose F 18 PET-CT and PET-MRI.
Conditions
- Recurrent Colon Cancer
- Recurrent Rectal Cancer
- Stage IIA Colon Cancer
- Stage IIA Rectal Cancer
- Stage IIB Colon Cancer
- Stage IIB Rectal Cancer
- Stage IIC Colon Cancer
- Stage IIC Rectal Cancer
- Stage IIIA Colon Cancer
- Stage IIIA Rectal Cancer
- Stage IIIB Colon Cancer
- Stage IIIB Rectal Cancer
- Stage IIIC Colon Cancer
- Stage IIIC Rectal Cancer
- Stage IVA Colon Cancer
- Stage IVA Rectal Cancer
- Stage IVB Colon Cancer
- Stage IVB Rectal Cancer
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | positron emission tomography | Undergo fludeoxyglucose F 18 PET-CT and PET-MRI |
| PROCEDURE | computed tomography | Undergo fludeoxyglucose F 18 PET-CT and PET-MRI |
| PROCEDURE | magnetic resonance imaging | Undergo fludeoxyglucose F 18 PET-CT and PET-MRI |
| RADIATION | fludeoxyglucose F 18 | Undergo fludeoxyglucose F 18 PET-CT and PET-MRI |
Timeline
- Start date
- 2013-04-01
- Primary completion
- 2014-03-05
- Completion
- 2014-03-05
- First posted
- 2013-03-08
- Last updated
- 2021-05-18
- Results posted
- 2021-05-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01807117. Inclusion in this directory is not an endorsement.